1-5 of 5
Simon McNamara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Indirect treatment comparison of belantamab mafodotin + pomalidomide + dexamethasone versus comparator regimens in lenalidomide-exposed relapsed/refractory multiple myeloma: A network meta-analysis

Free
Joshua Richter, Meral Beksac, Alessandro Corso, Ollie Schofield, Dani Olivier, Leanne Cooper, Owen Harrison, Jacopo Bitetti, Benga Kazeem, Alex Bates, Natalie Boytsov, Simon McNamara, Adil Merchant, Connor Lloyd, Christina-Jane Crossman-Morgan, Nicholas Meader, Molly Purser, Nick Ballew
Journal: Blood
Blood (2025) 146 (Supplement 1): 7567.
https://doi.org/10.1182/blood-2025-7567
Published: 2025
Journal Articles

Life-years and quality-adjusted life-years with belantamab mafodotin, bortezomib, and dexamethasone vs alternative regimens in patients with Relapsed/Refractory multiple myeloma who received ≥1 prior line of therapy

Free
Attaya Suvannasankha, Benga Kazeem, Paul MacLeod, Ewa Dlotko, Natalie Boytsov, Yevgeniy Samyshkin, Simon McNamara, Molly Purser, Sandhya Sapra, Martin Kaiser
Journal: Blood
Blood (2025) 146 (Supplement 1): 4041.
https://doi.org/10.1182/blood-2025-4041
Published: 2025
Journal Articles

The Impact of Patient-Reported Adverse Events on Quality of Life: An Analysis of the Dreamm-7 and Dreamm-8 Randomized Controlled Trials

Free
Angely Loubert, Laurine Bunod, Manal M'Hari, Farrah Pompilus, Molly Purser, Simon McNamara
Journal: Blood
Blood (2024) 144 (Supplement 1): 3358.
https://doi.org/10.1182/blood-2024-200299
Published: 2024
Journal Articles

Belantamab Mafodotin + Bortezomib + Dexamethasone Versus 2L+ Relapsed/Refractory Multiple Myeloma Regimens: Lenalidomide-Exposed, Lenalidomide-Refractory, High-Risk Cytogenic, and 2L-Only Subpopulations: A Network Meta-Analysis

Free
Paula Rodríguez-Otero, Joshua Richter, Ajay K. Nooka, Fredrik Schjesvold, Emily Combe, Leanne Cooper, Ollie Schofield, Indeg Sly, Nick Ballew, Jacopo Bitetti, Natalie Boytsov, Simon McNamara, Molly Purser
Journal: Blood
Blood (2024) 144 (Supplement 1): 7054.
https://doi.org/10.1182/blood-2024-198712
Published: 2024
Journal Articles

Real-World Outcomes of Medicare Fee-for-Service Beneficiaries Meeting the Eligibility Criteria for the DREAMM-7 and DREAMM-8 Clinical Trials

Free
Simon McNamara, Natalie Boytsov, Peter Feng Wang, Maya Hanna, Anjali Franco, Benjamin Lewing, Barth Kelly, Joseph Tkacz
Journal: Blood
Blood (2023) 142 (Supplement 1): 1965.
https://doi.org/10.1182/blood-2023-181668
Published: 2023